TABLE 1 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 2 GLOBAL MRI IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 3 GLOBAL PET/SPECT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 4 GLOBAL CT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 5 GLOBAL OPTICAL MINISCOPES IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 6 GLOBAL 2 PHOTON CONFOCAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 7 GLOBAL US IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 8 GLOBAL NIR FLUORESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 9 GLOBAL OCT IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 10 GLOBAL BIOLUMINESCENCE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 11 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 12 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 13 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 14 GLOBAL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 GLOBAL DISEASE CHARACTERIZATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 16 GLOBAL TOXICOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 17 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 18 GLOBAL ALZHEIMER'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 19 GLOBAL PARKINSON'S DISEASE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 20 GLOBAL ONCOLOGY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 21 GLOBAL OTHER THERAPEUTIC AREAS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 22 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 23 GLOBAL BOLD IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 24 GLOBAL OXYGENATION IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 25 GLOBAL BLOOD FLOW IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 26 GLOBAL MICROVESSELS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 27 GLOBAL NEURONAL ACTIVITY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 28 GLOBAL SOFT TISSUE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 29 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 30 GLOBAL UNDER AN HOUR IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 31 GLOBAL MANY HOURS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 32 GLOBAL LONGITUDINAL IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 33 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 34 GLOBAL PHARMA-INHOUSE IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 35 GLOBAL CRO IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 36 GLOBAL ACADEMIA IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 37 GLOBAL OTHERS IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 38 GLOBAL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY REGION, 2021-2030 (USD THOUSAND)
TABLE 39 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 40 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 41 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 42 NORTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 43 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 44 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 45 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 46 NORTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 47 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 48 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 49 U.S. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 50 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 51 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 52 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 53 U.S. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 54 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 55 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 56 CANADA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 57 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 58 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 59 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 60 CANADA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 61 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 62 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 63 MEXICO DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 65 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 66 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 67 MEXICO IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 68 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 69 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 70 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 71 EUROPE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 72 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 73 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 74 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 75 EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 76 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 78 GERMANY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 80 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 81 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 82 GERMANY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 83 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 84 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 85 FRANCE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 86 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 87 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 88 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 89 FRANCE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 90 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 92 U.K. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 94 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 95 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 96 U.K. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 97 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 98 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 99 ITALY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 100 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 101 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 102 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 103 ITALY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 104 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 105 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 106 SPAIN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 108 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 109 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 110 SPAIN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 111 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 113 RUSSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 114 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 115 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 116 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 117 RUSSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 118 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 119 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 120 TURKEY DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 121 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 122 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 123 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 124 TURKEY IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 125 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 126 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 127 BELGIUM DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 129 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 130 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 131 BELGIUM IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 132 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 133 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 134 NETHERLANDS DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 135 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 136 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 137 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 138 NETHERLANDS IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 139 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 141 SWITZERLAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 142 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 143 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 144 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 145 SWITZERLAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 146 REST OF EUROPE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 147 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 148 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 149 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 150 ASIA-PACIFIC DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 151 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 152 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 153 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 154 ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 155 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 157 JAPAN DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 158 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 159 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 160 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 161 JAPAN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 162 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 163 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 164 CHINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 165 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 166 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 167 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 168 CHINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 170 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 171 SOUTH KOREA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 173 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 174 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 175 SOUTH KOREA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 176 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 177 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 178 INDIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 179 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 180 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 181 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 182 INDIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 183 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 184 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 185 AUSTRALIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 187 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 188 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 189 AUSTRALIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 190 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 191 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 192 SINGAPORE DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 193 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 194 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 195 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 196 SINGAPORE IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 197 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 198 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 199 THAILAND DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 200 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 201 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 202 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 203 THAILAND IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 204 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 205 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 206 MALAYSIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 207 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 208 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 209 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 210 MALAYSIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 211 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 212 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 213 INDONESIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 214 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 215 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 216 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 217 INDONESIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 218 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 219 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 220 PHILIPPINES DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 221 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 222 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 223 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 224 PHILIPPINES IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 225 REST OF ASIA-PACIFIC IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 226 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 227 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 228 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 229 SOUTH AMERICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 230 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 231 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE, 2021-2030 (USD THOUSAND)
TABLE 232 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 233 SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 234 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 235 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 236 BRAZIL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 237 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 238 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 239 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 240 BRAZIL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 241 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 242 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 243 ARGENTINA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 244 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 245 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 246 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 247 ARGENTINA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 248 REST OF SOUTH AMERICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 249 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 250 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 251 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 252 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 253 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 254 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 255 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 256 MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 257 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 258 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 259 SOUTH AFRICA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 260 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 261 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 262 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 263 SOUTH AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 264 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 265 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 266 SAUDI ARABIA DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 267 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 268 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 269 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 270 SAUDI ARABIA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 271 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 272 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 273 U.A.E. DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 274 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 275 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 276 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 277 U.A.E. IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 278 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 279 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 280 EGYPT DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 281 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 282 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 283 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 284 EGYPT IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 285 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)
TABLE 286 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 287 ISRAEL DRUG DISCOVERY IN IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 288 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD THOUSAND)
TABLE 289 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY BIOLOGICAL VARIABLE 2021-2030 (USD THOUSAND)
TABLE 290 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY TEMPORAL FORMAT OF USE, 2021-2030 (USD THOUSAND)
TABLE 291 ISRAEL IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 292 REST OF MIDDLE EAST AND AFRICA IN VIVO PRECLINICAL BRAIN IMAGING DEVICES MARKET, BY IMAGING MODALITY TYPE, 2021-2030 (USD THOUSAND)